Published on 10 Aug 2022 on Zacks via Yahoo Finance
Cyclerion Therapeutics, Inc. (CYCN) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 8.82%. A quarter ago, it was expected that this company would post a loss of $0.36 per share when it actually produced a loss of $0.30, delivering a surprise of 16.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.